HOUSTON--(BUSINESS WIRE)--Jan. 26, 2006--CytoGenix, Inc. (OTCBB:CYGX) announced today that it has filed a patent application titled Method of Making Nucleic Acid Therapeutics with the US Patent and Trademark Office. Malcolm Skolnick, CytoGenix, Inc. CEO, commented, “We will seek broad protection for the application of our synDNA process and its applications to DNA vaccines. This application incorporates the results of our successful animal tests of DNA vaccines against Smallpox, Hepatitis B, Influenza and HIV and extends the range of the protection of our technology.”
